Nelli Morgulchik
AeroLeads people directory · profile

Nelli Morgulchik Email & Phone Number

Co-Founder at future.bio
Location: Tel Aviv-Yafo, Tel Aviv District, Israel 12 work roles 3 schools
LinkedIn matched
✓ Verified Jun 2026 3 data sources Profile completeness 100%

Contact Signals

LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
Role
Co-Founder
Location
Tel Aviv-Yafo, Tel Aviv District, Israel
Company size

Who is Nelli Morgulchik? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Nelli Morgulchik is listed as Co-Founder at future.bio, a company with 3 employees, based in Tel Aviv-Yafo, Tel Aviv District, Israel. AeroLeads shows a matched LinkedIn profile for Nelli Morgulchik.

Nelli Morgulchik previously worked as Bits and Bobs at Stealth and Investor - Biotech at Hummingbird Ventures. Nelli Morgulchik holds Masters Of Research - Mres, Drug Discovery And Development from Imperial College London.

Company email context

Email format at future.bio

This section adds company-level context without repeating Nelli Morgulchik's masked contact details.

future.bio

Review company-level records connected to Nelli Morgulchik before choosing the right outreach path.

Profile bio

About Nelli Morgulchik

.

Listed skills include Scientific Writing, Organization Skills, Public Speaking, Peer Tutoring, and 5 others.

Current workplace

Nelli Morgulchik's current company

Company context helps verify the profile and gives searchers a useful next step.

future.bio
Future.Bio
Co-Founder
Tel Aviv-Yafo, IL
Website
Employees
3
AeroLeads page
12 roles · 8 years

Nelli Morgulchik work experience

A career timeline built from the work history available for this profile.

Bits And Bobs

Current
Stealth

🤫

Nov 2024 - Present

Investor - Biotech

London, London, GB

Investing in early-stage bio companies across the globe - Pre-Seed to Series A 🧬Our bio companies include BillionToOne, Enveda Biosciences, Serna Bio, Waypoint Bio, Kernal Biologics, Automata, Basecamp Research, LatchBio, Kaleidoscope Bio, Amber Bio and Pheiron.

Jan 2024 - Oct 2024

Venture Development Associate

London, GB

  • Managed and delivered bespoke Accelerator Programmes for 100+ early-stage start-ups across life sciences and healthcare, providing commercial de-risking support and coaching
  • Expanded the ecosystem and partnerships by engaging with experts for mentorship and due diligence, and overseeing operational management, resulting in increased resources and support for startups
Jun 2022 - Dec 2023

Strategy & Partnerships Associate

London, GB

  • Formulated B2B sales strategy, set up >0.5B sales pipeline and onboarded sales executives
  • Managed a cross-functional team in the conceptualization and development of a new B2B product offering
  • Validated hypotheses through collecting and synthesizing customer data for product and marketing teams
  • Assisted C-suite in fundraising (preparing the grant application and pitch deck, building financial models)
Sep 2021 - May 2022

Analyst

New York City, NY, US

  • Drove market research across 10+ developed and emerging markets to deliver recommendations for product launch, value and access, life cycle management strategies as well as portfolio innovative contracting strategies
  • Sharpened expertise and awareness across multiple therapeutic areas including oncology, infectious and rare diseases
  • Engaged in thought leadership and podcast development on the pharmaceutical and biotech industry trends
Oct 2020 - Sep 2021

Researcher

UK, GB

  • Polygeia is a student-led global health think tank from the UK that created a COVID-19-focused research group - Student Collaborative for Extempore Research on COVID-19 (SCERC).
  • Conducted a systematic review on differences in risk, presentation and outcomes of COVID-19 in cancer patients across the world, published in Clinical Oncology
Apr 2020 - Jun 2020

Project Manager

London, Greater London, GB

  • Imperial Consulting Group is a non-profit strategy consulting firm run by high-performing students from Imperial College London.
  • Developed a market entry strategy for a novel dry eye disease diagnostic device pioneered by Tear Diagnostics, a spinout company from the Department of Chemical Engineering at Imperial College London
Jan 2020 - Mar 2020

Summer Associate

London, GB

  • applied strategic is a leading life science and pharmaceutical consultancy with 15+ years of experience.
  • Delineated an opportunity for a new oral diabetes product in US/Europe with a potential value of $500+ million, analysed 150+ scientific and commercial resources, wrote a 45+ page executive report and drafted a patent.
Jul 2019 - Aug 2019

Vice Chair

Cambridge, England, GB

  • Building Bridges in Medical Sciences is a one-day conference that brings together scientists from different disciplines, career stages and countries. The conference emphasises the need for interdisciplinary approaches.
  • Managed a team of 9 students organising a cross-disciplinary medical conference for 300+ postgraduate students with 8 acclaimed speakers from academia, industry, NGOs and start-ups
  • Launched a sponsorship campaign that secured Ā£14,000+ from academic and corporate organisations
Oct 2018 - Mar 2019

Co-Founder

Senseblock
  • Organised a multidisciplinary team of 5 students developing an innovative wearable device - SenseBlock - to detect arterial re-narrowing in atherosclerosis with projected Ā£5.5M in healthcare cost savings
  • Propelled the project to the semi-final of MedTech Venture Competition by the Judge BusinessSchool of the University of Cambridge beating 40+ emerging start-ups
  • Received an offer to join Accelerate Cambridge incubator
2018 - 2019 ~1 yr

Leader Of Tomorrow

Cambridge, Cambridgeshire, GB

  • GapSummit is an annual student-run, world-class biotechnology leadership summit organised by Global Biotech Revolution with the core objectives of substantively discussing pressing challenges facing the bio-economy and.
  • Selected among 100 students and early career professionals in pharmaceutical and biotechnological industries worldwide
  • Proposed a blockchain-based solution to fight health insurance fraud in the US, generated a 2-page business plan and prepared a pitch for the bio-innovation competition, Voices of Tomorrow
Jan 2018 - Apr 2018
3 education records

Nelli Morgulchik education

Masters Of Research - Mres, Drug Discovery And Development

Imperial College London

Ma Cantab, Biological Natural Sciences

University Of Cambridge

International Baccalaureate Diploma Programme

Sevenoaks School
FAQ

Frequently asked questions about Nelli Morgulchik

Quick answers generated from the profile data available on this page.

What company does Nelli Morgulchik work for?

Nelli Morgulchik works for future.bio.

What is Nelli Morgulchik's role at future.bio?

Nelli Morgulchik is listed as Co-Founder at future.bio.

Where is Nelli Morgulchik based?

Nelli Morgulchik is based in Tel Aviv-Yafo, Tel Aviv District, Israel while working with future.bio.

What companies has Nelli Morgulchik worked for?

Nelli Morgulchik has worked for Future.Bio, Stealth, Hummingbird Ventures, Pioneer Group, and Hertility.

How can I contact Nelli Morgulchik?

You can use AeroLeads to view verified contact signals for Nelli Morgulchik at future.bio, including work email, phone, and LinkedIn data when available.

What schools did Nelli Morgulchik attend?

Nelli Morgulchik holds Masters Of Research - Mres, Drug Discovery And Development from Imperial College London.

What skills is Nelli Morgulchik known for?

Nelli Morgulchik is listed with skills including Scientific Writing, Organization Skills, Public Speaking, Peer Tutoring, Teamwork, Volunteering, Research, and Leadership.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.